More
    Guided Solutions - Connecting Talent With Innovation/div>

    Wandercraft raises $75M to support AI-powered robotic exoskeleton

    Wandercraft announced it secured $75 million in funding as part of its Series D financing round to support its robotic exoskeleton. Renault Group, PSIM fund,...

    Atraverse raises $29.4M for left-heart access device

    Atraverse Medical closed a $29.4 million follow-on financing round to help accelerate growth. The San Diego-based company secured an oversubscribed seed funding round worth $12.5...

    Flux Robotics secures pre-seed funding to accelerate safer magnetic surgeries

    Flux Robotics announces the successful closing of its pre-seed round, supported by Future Tech Ventures and NextGen Ventures. This investment is further complemented by...

    Dilon Technologies closes $9m in Growth Capital Financing

    Dilon Technologies, a global leader in medical devices for biosurgery and breast cancer treatment and diagnosis, announced a $9 million growth capital investment from...

    AIATELLA raises €2m for AI-powered cardiovascular imaging tools

    Finnish MedTech startup AIATELLA has secured 2 million EUR in funding to accelerate the development and scaling of its AI-powered cardiovascular imaging technology. The...

    Brainreader secures €6.6m for brain diagnostic commercialisation

    Danish MedTech Brainreader has secured €6.6m ($7.3m) to support the market rollout of Neuroreader, its AI-based brain diagnostic software platform. The funding round was led...

    Surgify Medical secures $7.97M to advance bone surgery technology

    Finnish company Surgify Medical has secured €7m ($7.97m) in Series A funding to expand the reach of its Surgify Halo technology, which aims to...

    EBR Systems raises $36.1M for leadless pacing tech

    EBR Systems received commitments for a fully underwritten institutional placement to raise $36.1 million (A$55.9 million). In addition to the committed funding, the company...

    Salvia BioElectronics secures $60M in oversubscribed Series B round

    Salvia BioElectronics, a clinical-stage medical device company pioneering neuromodulation therapy for people with chronic migraine, announced the successful completion of a $60 million (€53...

    Latest articles